Cannabinoids as Glial Cell Modulators in Ischemic Stroke: Implications for Neuroprotection
Abstract Stroke is the second leading cause of death worldwide following coronary heart disease. Despite significant efforts to find effective…
Abstract Stroke is the second leading cause of death worldwide following coronary heart disease. Despite significant efforts to find effective…
Abstract Autism spectrum disorder (ASD) and associated neurodevelopmental disorders share similar pathogenesis and clinical features. Pathophysiological changes in these diseases…
Abstract Palmitoylethanolamide (PEA) stands out among endogenous lipid mediators for its neuroprotective, anti-inflammatory, and analgesic functions. PEA belonging to the…
Abstract Accumulating data suggest that chronic neuroinflammation-mediated neurodegeneration is a significant contributing factor for progressive neuronal and glial cell death…
Abstract We have previously shown that bilateral common carotid artery occlusion followed by reperfusion (BCCAO/R) is a model to study…
Abstract Despite current therapeutic strategies for immunomodulation and relief of symptoms in multiple sclerosis (MS), remyelination falls short due to…
Abstract Microglia, the resident immune cells of the brain, can take on a range of pro- or anti-inflammatory phenotypes to…
Abstract WVSPLAGRT (H2) and IGFLIIWV (H3) are two transepithelial transported intestinal peptides obtained from the hydrolysis of hempseed protein with…
Abstract Epilepsy is one of the most common neurological conditions. Yearly, five million people are diagnosed with epileptic-related disorders. The…
Abstract Major depressive disorder is a high-impact, debilitating disease and it is currently considered the most prevalent mental illness. It…